General Information of MIC (ID: MIC01134)
MIC Name Ruminococcus callidus (firmicutes)
Body Site Gut
Lineage Kingdom: Bacteria
Phylum: Firmicutes
Class: Clostridia
Order: Clostridiales
Family: Ruminococcaceae
Genus: Ruminococcus
Species: Ruminococcus callidus
Oxygen Sensitivity Obligate anaerobe
Microbial Metabolism Saccharolytic; Fermentative
Gram Positive
Genome Size (bp) 3070687
Description Ruminococcus callidus is a member of the division Firmicutes and Gram-positive. Ruminococcus callidus, isolated from the human gut, is able to degrade complex polysaccharides such as starch or xylan.
External Links Taxonomy ID
40519
Genome Assembly ID
ASM46801v1
GOLD Organism ID
Go0000917
Disease Relevance
          Crohn disease  [ICD-11: DD70]
             Description Ruminococcus callidus were more abundant in the healthy subjects than in the Crohns disease patients. [1]
          Parkinsonism  [ICD-11: 8A00]
             Description Ruminococcus callidus was associated with parkinsons disease. [2]
Host Genetic Factors (HGFs)
          C4B
             HGF ID HGF2348 HGF Info       Class Copy Number Variation: Gene Duplication (CNV-GDu)
             Description The low C4B-CN has been significantly associated with the high abundance of Ruminococcus (p-value<0.05). [3]
          rs2066842
             HGF ID HGF1456 HGF Info       Class Single Nucleotide Polymorphism: Missense variant (SNP-MV)
             Description The variant gene NOD2 of innate immunity rs2066842 is significantly associated with the abundance of gut micriobiota Ruminococcus callidus (p-value<0.0001). [4]
Host Immune Factors (HIFs)
          Interferon-15
             HIF ID HIFM0133 HIF Info       Class Cytokine (Cyt)
             Description Ruminococcus callidus induce a significant reduction in the pro-inflammatory cytokine interleukin-15. [5]
Environmental Factor(s)
             Disbiome ID
      75
             gutMDisorder ID
      gm0589
References
1 Dysbiosis of fecal microbiota in Crohn's disease patients as revealed by a custom phylogenetic microarray. Inflamm Bowel Dis. 2010 Dec;16(12):2034-42. doi: 10.1002/ibd.21319.
2 Analysis of Gut Microbiota in Patients with Parkinson's Disease. Bull Exp Biol Med. 2017 Apr;162(6):734-737. doi: 10.1007/s10517-017-3700-7. Epub 2017 Apr 20.
3 C4B gene influences intestinal microbiota through complement activation in patients with paediatric-onset inflammatory bowel disease.Clin Exp Immunol. 2017 Dec;190(3):394-405. doi: 10.1111/cei.13040. Epub 2017 Sep 25.
4 Variants in genes of innate immunity, appetite control and energy metabolism are associated with host cardiometabolic health and gut microbiota composition.Gut Microbes. 2020 May 3;11(3):556-568. doi: 10.1080/19490976.2019.1619440. Epub 2019 Jun 3.
5 Effect of Lactobacillus paracasei CNCM I-1572 on symptoms, gut microbiota, short chain fatty acids, and immune activation in patients with irritable bowel syndrome: A pilot randomized clinical trial. United European Gastroenterol J. 2018 May;6(4):604-613. doi: 10.1177/2050640617736478. Epub 2017 Oct 8.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.